Sabra Health Care REIT, Inc. (SBRA)

Sabra Health Care REIT Stock Forecast

Stock Price Forecast

The 8 analysts that cover Sabra Health Care REIT stock have a consensus rating of "Hold" and an average price target of $20.5, which forecasts a 13.51% increase in the stock price over the next year. The lowest target is $20 and the highest is $22.

Price Target: $20.5 (+13.51%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$20	$20.5	$20	$22
Change	+10.74%	+13.51%	+10.74%	+21.82%

Analyst Ratings

The average analyst rating for Sabra Health Care REIT stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	May '25	Jun '25	Jul '25	Aug '25	Sep '25	Oct '25
Strong Buy	1	1	1	1	1	0
Buy	3	3	3	3	3	3
Hold	3	3	3	4	4	5
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	7	7	8	8	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
John Kilichowski Wells Fargo	Wells Fargo	Buy Maintains $21 → $20	Buy	Maintains	$21 → $20	+10.74%	Oct 21, 2025
Richard Anderson Cantor Fitzgerald	Cantor Fitzgerald	Hold Initiates $20	Hold	Initiates	$20	+10.74%	Oct 1, 2025
Michael Lewis Truist Securities	Truist Securities	Hold Maintains $18 → $20	Hold	Maintains	$18 → $20	+10.74%	Sep 3, 2025
John Kilichowski Wells Fargo	Wells Fargo	Buy Maintains $20 → $21	Buy	Maintains	$20 → $21	+16.28%	Aug 27, 2025
John Kim BMO Capital	BMO Capital	Hold Maintains $19 → $22	Hold	Maintains	$19 → $22	+21.82%	Aug 25, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

754.36M

Increased by 7.36%

from 702.64M

Revenue Next Year

820.45M

Increased by 8.76%

from 754.36M

EPS This Year

0.76

Increased by 40.41%

from 0.54

EPS Next Year

0.79

Increased by 4.26%

from 0.76

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	600.82M	388.24M	531.95M	644.62M	702.64M	754.36M	820.45M
Revenue Growth	-10.08%	-35.38%	37.02%	21.18%	9.00%	7.36%	8.76%
EPS	0.67	-0.52	-0.34	0.06	0.54	0.76	0.79
EPS Growth	81.76%	-	-	-	807.61%	40.41%	4.26%
Forward PE	-	-	-	-	-	23.82	22.85
No. Analysts	-	-	-	-	-	8	8

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	821.0M	992.7M
Avg	754.4M	820.5M
Low	692.7M	721.7M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	16.8%	31.6%
Avg	7.4%	8.8%
Low	-1.4%	-4.3%

EPS Forecast

EPS	2025	2026	2027
High	0.86	0.88
Avg	0.76	0.79
Low	0.67	0.72

EPS Growth

EPS Growth	2025	2026	2027
High	59.4%	16.3%
Avg	40.4%	4.3%
Low	23.4%	-5.6%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.